DocGo Inc. (DCGO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value |
| Current obligations | 72.33M USD | Liabilities, Current |
| Cash and equivalents | 25.23M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $72.33M | $25.23M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $77.22M | $35.68M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $67.49M | $51.02M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $73.58M | $73.36M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $100.15M | $104.16M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $107.57M | $79.01M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $121.81M | $89.24M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $150.23M | $89.46M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $154.12M | $66.06M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $160.14M | $41.24M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $170.12M | $59.29M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $113.06M | $52.92M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $91.76M | $109.16M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $108.97M | $120.06M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $100.16M | $157.34M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $71.14M | $169.60M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $57.94M | $198.14M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $60.99M | $188.35M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $57.88M | $175.54M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $334.18K | $59.32K | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $163.79K | $234.16K | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $184.01K | $498.82K | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $159.85K | $878.65K | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $91.61K | $1.53K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |